ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,764.00
0.35%
S&P ASX All Technology
3,060.10
0.66%
Brent Oil
77.505
0.51%
US Dollar vs AUD
1.50105
-0.24%
Bitcoin
70,866.12
0.43%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nexmed (MM) (NEXM)

  7. Nexmed (MM) (NEXM) News

NEXM

Nexmed (MM) (NEXM)

Nexmed (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NEXM
DateTimeSourceHeadlineSymbolCompany
11/09/201007:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
11/09/201006:31Business WireNexMed, Inc. Announces Results of Special Meeting of Stockholders, Including Name Change to Apricus BiosciencesNASDAQ:NEXMNexmed (MM)
01/09/201007:18Edgar (US Regulatory)Securities Registration Statement (S-1)NASDAQ:NEXMNexmed (MM)
26/08/201001:00Business WireNexMed To Present at the Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:NEXMNexmed (MM)
23/08/201023:00Business WireNexMed Receives Additional Patent Coverage for IsraelNASDAQ:NEXMNexmed (MM)
20/08/201007:20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
17/08/201020:03Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NEXMNexmed (MM)
13/08/201007:10Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
11/08/201023:15Business WireNexMed Announces 2010 Second Quarter Financial Results Conference CallNASDAQ:NEXMNexmed (MM)
07/08/201004:34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:NEXMNexmed (MM)
27/07/201002:36Business WireMohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USANASDAQ:NEXMNexmed (MM)
21/06/201023:15GlobeNewswire Inc.Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc.NASDAQ:NEXMNexmed (MM)
18/06/201007:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
16/06/201004:48Business WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
15/06/201023:20Business WireNexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioeq...NASDAQ:NEXMNexmed (MM)
11/06/201003:30Business WireNexMed Provides Update on Canadian Filing for Vitaros®NASDAQ:NEXMNexmed (MM)
28/05/201003:16Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
27/05/201008:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
27/05/201005:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NEXMNexmed (MM)
26/05/201007:00Business WireNexMed Announces Expansion of Senior Business Development TeamNASDAQ:NEXMNexmed (MM)
18/05/201007:11Business WireNexMed to Discuss P2/3 Protocol for NexACT®-Based Alprostadil Treatment for Raynaud’s Syndrome with the FDANASDAQ:NEXMNexmed (MM)
14/05/201007:09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:NEXMNexmed (MM)
13/05/201007:01Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
13/05/201006:30Business WireNexMed Announces Pre-Clinical Study Showing Vitaros® Significantly Promotes Wound HealingNASDAQ:NEXMNexmed (MM)
11/05/201007:19Business WireNexMed Announces Encouraging Pre-Clinical Results Showing the Ability of the NexACT® Technology to Enhance the Bioavailabili...NASDAQ:NEXMNexmed (MM)
07/05/201019:50GlobeNewswire Inc.BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfitNASDAQ:NEXMNexmed (MM)
07/05/201006:45Business WireNexMed Expands Scientific Advisory Board with Appointment of Key Industry LeadersNASDAQ:NEXMNexmed (MM)
06/05/201006:36Business WireNexMed Announces Patent Allowance for NexACT® in CanadaNASDAQ:NEXMNexmed (MM)
01/05/201004:53Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:NEXMNexmed (MM)
29/04/201020:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NEXMNexmed (MM)
 Showing the most relevant articles for your search:NASDAQ:NEXM

Your Recent History

ASX
XAO
Australian SE All Ordina...
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
FX
AUDJPY
AUD vs Yen
ASX
NCM
Newcrest Mining
NYSE
MRK
Merck
ASX
BHP
BHP
ASX
CSL
CSL
SPI
SP500
S&P 500
NYSE
VZ
Verizon Communications
ASX
WES
Wesfarmers
ASX
QBE
QBE Insurance
ASX
WOW
Woolworths
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved